Propranolol Ameliorates the Antifungal Activity of Azoles in Invasive Candidiasis.

ABSTRACT: The effectiveness of current antifungal therapies is hampered by the emergence of drug resistance strains, highlighting an urgent need for new alternatives such as adjuvant antifungal treatments. This study aims to examine the synergism between propranolol and antifungal drugs, based on the premise that propranolol is known to inhibit fungal hyphae. In vitro studies demonstrate that propranolol potentiates the antifungal activity of azoles and that the effect is more pronounced for propranolol-itraconazole combination. Using an in vivo murine systemic candidemia model, we show that propranolol-itraconazole combination treatment resulted in a lower rate of body weight loss, decreased kidney fungal bioburden and renal inflammation when compared to propranolol and azole treatment alone or unt

SUBMITTER: Mayandi V 

PROVIDER: S-EPMC10144167 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature